Skip to main content
SpringerLink
Log in

Depression and Anxiety

  • Chapter
  • First Online:
Book cover Neuropsychiatric Dysfunction in Multiple Sclerosis

Abstract

Major Depressive Disorder (MDD) is very common in patients with Multiple Sclerosis (MS), with a lifetime prevalence of up to 50 % [1]. In the last 15–20 years various studies have revealed that the annual prevalence of MDD in MS is higher compared both to the general population and people with different chronic medical conditions. In MS patients aged between 18 and 45, an annual prevalence of 25.7 % has been reported [2]. Interestingly, psychological distress in MS patients is associated with neurological disability, but is also present in patients with minimal or no neurological disability. Major Depression and affective disturbances in general are identified as an independent predictor for MS-related quality of life [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feinstein A (2004) The neuropsychiatry of multiple sclerosis. Can J Psychiatry 49:157–163

    PubMed  Google Scholar 

  2. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology. Neurology 9(61):1524–1527

    Article  Google Scholar 

  3. Kern S, Ziemssen T (2008) Brain-immune communication. Psychoneuroimmunology of multiple sclerosis. Mult Scler 14:6–21

    Article  PubMed  CAS  Google Scholar 

  4. Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 10(59):674–678

    Article  Google Scholar 

  5. Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 47:98–104

    Article  PubMed  CAS  Google Scholar 

  6. Minden SL, Orav J, Reich P (1987) Depression in multiple sclerosis. Gen Hosp Psychiatry 9:426–434

    Article  PubMed  CAS  Google Scholar 

  7. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44:376–378

    Article  PubMed  CAS  Google Scholar 

  8. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW (1996) Depression and multiple sclerosis. Neurology 46:628–632

    Article  PubMed  CAS  Google Scholar 

  9. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159:1862–1868

    Article  PubMed  Google Scholar 

  10. Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I (1995) A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 36:390–395

    Article  PubMed  CAS  Google Scholar 

  11. Stenager E, Knudsen L, Jensen K (1994) Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction. Ital J Neurol Sci 15:97–101

    Article  PubMed  CAS  Google Scholar 

  12. Feinstein A, O’Connor P, Gray T, Feinstein K (1999) The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 5:323–326

    PubMed  CAS  Google Scholar 

  13. Stenager EN, Stenager E, Koch-Henriksen N, Brønnum-Hansen H, Hyllested K, Jensen K, Bille-Brahe U (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55:542–545

    Article  PubMed  CAS  Google Scholar 

  14. Janssens AC, Buljevac D, van Doorn PA, van der Meché FG, Polman CH, Passchier J, Hintzen RQ (2006) Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study. Mult Scler 12:794–801

    Article  PubMed  CAS  Google Scholar 

  15. Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13:67–72

    Article  PubMed  CAS  Google Scholar 

  16. Arnett PA, Randolph JJ (2006) Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 77:606–610

    Article  PubMed  CAS  Google Scholar 

  17. McCabe MP (2005) Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 59:161–166

    Article  PubMed  Google Scholar 

  18. Amato MP, Zipoli V, Portaccio E (2006) Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 15(245):41–46

    Article  Google Scholar 

  19. Dalos NP, Rabins PV, Brooks BR, O’Donnell P (1983) Disease activity and emotional state in multiple sclerosis. Ann Neurol 13:573–577

    Article  PubMed  CAS  Google Scholar 

  20. Warren S, Warren KG, Cockerill R (1991) Emotional stress and coping in multiple sclerosis (MS) exacerbations. J Psychosom Res 35:37–47

    Article  PubMed  CAS  Google Scholar 

  21. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A (1994) Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 89:117–121

    Article  PubMed  Google Scholar 

  22. Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (2006) Relationship between stress and relapse in multiple sclerosis: Part I Important features. Mult Scler 12:453–464

    Article  PubMed  CAS  Google Scholar 

  23. Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196

    Article  PubMed  CAS  Google Scholar 

  24. Klapper JA (1994) Interferon beta treatment of multiple sclerosis. Neurology 44:188

    Article  PubMed  CAS  Google Scholar 

  25. Pandya R, Patten S (2002) Depression in multiple sclerosis associated with interferon beta-1a. Can J Psychiatry 47:686

    PubMed  Google Scholar 

  26. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 28(343):898–904

    Article  Google Scholar 

  27. Fragoso YD, Frota ER, Lopes JS, Noal JS, Giacomo MC, Gomes S, Gonçalves MV, da Gama PD, Finkelsztejn A (2010) Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 33:312–316

    Article  PubMed  CAS  Google Scholar 

  28. Mohr DC, Goodkin DE, Masuoka L, Dick LP, Russo D, Eckhardt J, Boudewyn AC, Bedell L (1999) Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. Mult Scler 5:192–197

    PubMed  CAS  Google Scholar 

  29. Patten SB, Metz LM (2001) Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Mult Scler 7:243–248

    PubMed  CAS  Google Scholar 

  30. Zephir H, De Seze J, Sénéchal O, Stojkovic T, Ferriby D, Deliss B, Dubus B, Verier A, Hautecoeur P, Vermersch P (2002) Treatment of progressive multiple sclerosis with cyclophosphamide. Rev Neurol (Paris) 158:65–69

    CAS  Google Scholar 

  31. Porcel J, Río J, Sánchez-Betancourt A, Arévalo MJ, Tintoré M, Téllez N, Borràs C, Nos C, Montalbán X (2006) Long-term emotional state of multiple sclerosis patients treated with interferon beta. Mult Scler 12:802–807

    Article  PubMed  CAS  Google Scholar 

  32. Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45:33–38

    Article  PubMed  CAS  Google Scholar 

  33. Kesselring J, Beer S (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4:643–652

    Article  PubMed  Google Scholar 

  34. Krupp LB, Christodoulou C (2001) Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 1:294–298

    Article  PubMed  CAS  Google Scholar 

  35. Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, Siracusa G, Masini M, Sorbi S, Trojano M (2006) Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 253:1054–1059

    Article  PubMed  Google Scholar 

  36. Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347:858–861

    Article  PubMed  CAS  Google Scholar 

  37. Téllez N, Río J, Tintoré M, Nos C, Galán I, Montalban X (2006) Fatigue in multiple sclerosis persists over time: a longitudinal study. J Neurol 253:1466–1470

    Article  PubMed  Google Scholar 

  38. Mohr DC, Hart SL, Goldberg A (2003) Effects of treatment for depression on fatigue in multiple sclerosis. Psychosom Med 65:542–547

    Article  PubMed  Google Scholar 

  39. Kinsinger SW, Lattie E, Mohr DC (2010) Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 24:573–580

    Article  PubMed  Google Scholar 

  40. Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151

    Article  PubMed  Google Scholar 

  41. Bruce J, Arnett P (2004) Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 26:200–214

    Article  PubMed  Google Scholar 

  42. Randolph JJ, Arnett PA, Freske P (2004) Metamemory in multiple sclerosis: Exploring affective and executive contributors. Arch Clin Neuropsychol 19:259–279

    Article  PubMed  Google Scholar 

  43. Middleton LS, Denney DR, Lynch SG, Parmenter BA (2006) The relationship between perceived and objective cognitive functioning in multiple sclerosis. Arch Clin Neuropsychol 21:487–494

    Article  PubMed  Google Scholar 

  44. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691

    Article  PubMed  CAS  Google Scholar 

  45. Achiron A, Barak Y (2006) Cognitive changes in early MS: a call for a common framework. J Neurol Sci 245:47–51

    Article  PubMed  CAS  Google Scholar 

  46. Jønsson A, Andresen J, Storr L, Tscherning T, Soelberg Sørensen P, Ravnborg M (2006) Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci 245:77–85

    Article  PubMed  Google Scholar 

  47. Schulz D, Kopp B, Kunkel A, Faiss JH (2006) Cognition in the early stage of multiple sclerosis. J Neurol 253:1002–1010

    Article  PubMed  Google Scholar 

  48. Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, Cherif AA, Pelletier J (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13:124–127

    Article  PubMed  CAS  Google Scholar 

  49. Feinstein A (2006) Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci 245:63–66

    Article  PubMed  Google Scholar 

  50. Gold SM, Irwin MR (2006) Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Neurol Clin 24:507–519

    Article  PubMed  Google Scholar 

  51. Nyenhuis DL, Luchetta T, Yamamoto C et al (1998) The development, standardization, and initial validation of the Chicago multiscale depression inventory. J Pers Assess 70:386–401

    Article  PubMed  CAS  Google Scholar 

  52. Solari A, Motta A, Mendozzi L et al (2003) Italian version of the Chicago Multiscale Depression Inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci 24:375–383

    Google Scholar 

  53. Mohr DC, Hart SL, Fonareva I, Tasch ES (2006) Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 12:204–208

    Article  PubMed  CAS  Google Scholar 

  54. Goldman Consensus Group (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11:328–337

    Article  Google Scholar 

  55. Cetin K, Johnson KL, Ehde DM, Kuehn CM, Amtmann D, Kraft GH (2007) Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample. Mult Scler 13:1046–1053

    Article  PubMed  CAS  Google Scholar 

  56. Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497

    PubMed  CAS  Google Scholar 

  57. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L (2001) Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942–949

    Article  PubMed  CAS  Google Scholar 

  58. Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J (2011) Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev 16(2):CD007295

    Google Scholar 

  59. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van Der Wende J, Dwyer P, Dick LP (2000) Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 68:356–361

    Article  PubMed  CAS  Google Scholar 

  60. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch ET (2005) Telephone-administered psychotherapy for depression. Arch Gen Psychiatry 62:1007–1014

    Article  PubMed  Google Scholar 

  61. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432–441

    Article  PubMed  CAS  Google Scholar 

  62. Brown TR, Kraft GH (2005) Exercise and rehabilitation for individuals with multiple sclerosis. Phys Med Rehabil Clin N Am 16:513–555

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatric Division, University Hospital Tor Vergata, Rome, Italy

    Prof. Alberto Siracusano, Cinzia Niolu, Lucia Sacchetti & Dr. Michele Ribolsi

Authors
  1. Prof. Alberto Siracusano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cinzia Niolu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Sacchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. Michele Ribolsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele Ribolsi .

Editor information

Editors and Affiliations

  1. IRCCS, Fondazione Santa Lucia, Via Ardeatina 306, Roma, 00179, Italy

    Ugo Nocentini

  2. IRCCS, Fondazione Santa Lucia, Via Ardeatina 306, Roma, 00179, Italy

    Carlo Caltagirone

  3. Istituto di Scienze, Neurologiche, Seconda Univ. di Napoli, Via Pansini 5, Napoli, 80131, Italy

    Gioacchino Tedeschi

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Siracusano, A., Niolu, C., Sacchetti, L., Ribolsi, M. (2013). Depression and Anxiety. In: Nocentini, U., Caltagirone, C., Tedeschi, G. (eds) Neuropsychiatric Dysfunction in Multiple Sclerosis. Springer, Milano. https://doi.org/10.1007/978-88-470-2676-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2676-6_11

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2675-9

  • Online ISBN: 978-88-470-2676-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation